Impact of sumatriptan on clinic utilization and costs of care in migraineurs

Headache

Volumn 36, Issue 9, 1996, Pages 538-541

  Litaker, David G ^a   Solomon, Glen D ^a   Genzen, Jonathan R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

medical effectiveness; migraine; sumatriptan

Indexed keywords

SUMATRIPTAN;

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN CLINICS; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN;

EID: 0029862140     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3609538.x     Document Type: Article

References (14)

1. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed Healthcare setting. Ann Pharmacother. 1994;28:659-664.
2. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics. 1992;2:67-76.
3. Kozma CM, Mauch RP, Reeder CE, Lawrence BJ. A literature review comparing the economic, clinical, and humanistic attributes of dihydroergotamine and sumatriptan. Clin Ther. 1994;16:1037-1051.
4. Gunderson CH. The impact of new pharmaceutical agents on the cost of neurologic care. Neurology. 1995;45:569-572.
5. Stewart WF, Lipton RB. The economic and social impact of migraine. Eur Neurol. 1994;34(suppl 2):12-17.
6. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993;20:131-137.
7. Stang PE, Osterhaus JT, Celentano DD. Migraine. Patterns of healthcare use. Neurology. 1994;44(suppl 4):S47-S55.
8. de Lissovoy G, Lazarus SS. The economic cost of migraine. Present state of knowledge. Neurology. 1994;44(suppl 4):S56-S62.
9. Prevalence of chronic migraine headaches - United States, 1980-1989. MMWR Morb Mortal Wkly Rep. 1991;40:331,337-338.
10. Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample survey. Headache. 1992;32:223-228.
11. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):19-28.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
13. Solomon GD, Nielson K, Miller D. The effects of sumatriptan on migraine: health-related quality of life. Med Interface. 1995:134-141.
14. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991;265:2831-2835.